Rosie Cunningham-Thomas
Directeur/Membre du Conseil chez The British Diabetic Association
Profil
Rosie Cunningham-Thomas has worked as a Trustee for The British Diabetic Association since 2017.
Postes actifs de Rosie Cunningham-Thomas
| Sociétés | Poste | Début |
|---|---|---|
The British Diabetic Association
 The British Diabetic Association Miscellaneous Commercial ServicesCommercial Services The British Diabetic Association is a leading charity in the UK that funds world-class diabetes research. The non-profit company is based in the UK. The British company has around 120 diabetes research projects at any given time, which are made possible by the support of their members, donors, and local groups. Each research project is reviewed by experts and approved by their research committee and panel of people living with diabetes. The company's vision is a world where diabetes can do no harm, and they invest in pioneering research into all forms of diabetes and diabetes-related complications. In 2021, they invested over £6.4 million in diabetes research to kick start 31 new studies. The company was founded in 1934 by HG Wells, RD Lawrence. | Directeur/Membre du Conseil | 01/07/2017 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
The British Diabetic Association
The British Diabetic Association Miscellaneous Commercial ServicesCommercial Services The British Diabetic Association is a leading charity in the UK that funds world-class diabetes research. The non-profit company is based in the UK. The British company has around 120 diabetes research projects at any given time, which are made possible by the support of their members, donors, and local groups. Each research project is reviewed by experts and approved by their research committee and panel of people living with diabetes. The company's vision is a world where diabetes can do no harm, and they invest in pioneering research into all forms of diabetes and diabetes-related complications. In 2021, they invested over £6.4 million in diabetes research to kick start 31 new studies. The company was founded in 1934 by HG Wells, RD Lawrence. | Commercial Services |